nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—CXCL8—malignant glioma	0.431	0.555	CbGaD
Ketoprofen—PTGS1—malignant glioma	0.22	0.283	CbGaD
Ketoprofen—PTGS2—malignant glioma	0.126	0.162	CbGaD
Ketoprofen—SLC22A8—choroid plexus—malignant glioma	0.00992	0.351	CbGeAlD
Ketoprofen—Retinal haemorrhage—Carmustine—malignant glioma	0.00338	0.0544	CcSEcCtD
Ketoprofen—Personality disorder—Carmustine—malignant glioma	0.00255	0.041	CcSEcCtD
Ketoprofen—Necrosis—Carmustine—malignant glioma	0.0014	0.0226	CcSEcCtD
Ketoprofen—CXCL8—medulla oblongata—malignant glioma	0.00117	0.0415	CbGeAlD
Ketoprofen—Hearing impaired—Temozolomide—malignant glioma	0.00112	0.018	CcSEcCtD
Ketoprofen—CXCL8—midbrain—malignant glioma	0.00107	0.038	CbGeAlD
Ketoprofen—CXCL8—spinal cord—malignant glioma	0.00105	0.037	CbGeAlD
Ketoprofen—Aplastic anaemia—Temozolomide—malignant glioma	0.000999	0.0161	CcSEcCtD
Ketoprofen—Gynaecomastia—Carmustine—malignant glioma	0.000986	0.0159	CcSEcCtD
Ketoprofen—Sepsis—Carmustine—malignant glioma	0.000956	0.0154	CcSEcCtD
Ketoprofen—PTGS1—endothelium—malignant glioma	0.000925	0.0328	CbGeAlD
Ketoprofen—Diabetes mellitus—Carmustine—malignant glioma	0.000919	0.0148	CcSEcCtD
Ketoprofen—Eye pain—Carmustine—malignant glioma	0.000886	0.0142	CcSEcCtD
Ketoprofen—PTGS2—endothelium—malignant glioma	0.000884	0.0313	CbGeAlD
Ketoprofen—Vascular purpura—Temozolomide—malignant glioma	0.000864	0.0139	CcSEcCtD
Ketoprofen—Deafness—Temozolomide—malignant glioma	0.000864	0.0139	CcSEcCtD
Ketoprofen—Eye pain—Temozolomide—malignant glioma	0.000856	0.0138	CcSEcCtD
Ketoprofen—PTGS1—blood vessel—malignant glioma	0.000853	0.0302	CbGeAlD
Ketoprofen—Amnesia—Carmustine—malignant glioma	0.000851	0.0137	CcSEcCtD
Ketoprofen—CXCL8—cerebellum—malignant glioma	0.000829	0.0294	CbGeAlD
Ketoprofen—Amnesia—Temozolomide—malignant glioma	0.000822	0.0132	CcSEcCtD
Ketoprofen—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000819	0.0132	CcSEcCtD
Ketoprofen—PTGS2—blood vessel—malignant glioma	0.000816	0.0289	CbGeAlD
Ketoprofen—Thirst—Temozolomide—malignant glioma	0.000812	0.0131	CcSEcCtD
Ketoprofen—Hyponatraemia—Carmustine—malignant glioma	0.000803	0.0129	CcSEcCtD
Ketoprofen—Purpura—Temozolomide—malignant glioma	0.000802	0.0129	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.0008	0.0129	CcSEcCtD
Ketoprofen—Face oedema—Carmustine—malignant glioma	0.000772	0.0124	CcSEcCtD
Ketoprofen—Face oedema—Temozolomide—malignant glioma	0.000746	0.012	CcSEcCtD
Ketoprofen—SLCO1A2—telencephalon—malignant glioma	0.000731	0.0259	CbGeAlD
Ketoprofen—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000696	0.0112	CcSEcCtD
Ketoprofen—CXCL8—brain—malignant glioma	0.000673	0.0239	CbGeAlD
Ketoprofen—Erectile dysfunction—Temozolomide—malignant glioma	0.000615	0.00989	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Temozolomide—malignant glioma	0.00061	0.00981	CcSEcCtD
Ketoprofen—Weight increased—Temozolomide—malignant glioma	0.000608	0.00978	CcSEcCtD
Ketoprofen—Renal failure—Carmustine—malignant glioma	0.000606	0.00974	CcSEcCtD
Ketoprofen—Weight decreased—Temozolomide—malignant glioma	0.000604	0.00972	CcSEcCtD
Ketoprofen—Stomatitis—Carmustine—malignant glioma	0.000601	0.00966	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00059	0.0095	CcSEcCtD
Ketoprofen—Stomatitis—Temozolomide—malignant glioma	0.00058	0.00934	CcSEcCtD
Ketoprofen—SLCO1A2—medulla oblongata—malignant glioma	0.000574	0.0203	CbGeAlD
Ketoprofen—Hallucination—Carmustine—malignant glioma	0.00055	0.00885	CcSEcCtD
Ketoprofen—SLC22A7—brain—malignant glioma	0.000545	0.0193	CbGeAlD
Ketoprofen—Hepatitis—Temozolomide—malignant glioma	0.000535	0.0086	CcSEcCtD
Ketoprofen—Visual impairment—Carmustine—malignant glioma	0.000533	0.00857	CcSEcCtD
Ketoprofen—Hallucination—Temozolomide—malignant glioma	0.000532	0.00856	CcSEcCtD
Ketoprofen—Pharyngitis—Temozolomide—malignant glioma	0.000531	0.00853	CcSEcCtD
Ketoprofen—SLC22A6—brain—malignant glioma	0.000526	0.0186	CbGeAlD
Ketoprofen—SLCO1A2—midbrain—malignant glioma	0.000525	0.0186	CbGeAlD
Ketoprofen—Visual impairment—Temozolomide—malignant glioma	0.000515	0.00829	CcSEcCtD
Ketoprofen—Flushing—Carmustine—malignant glioma	0.000513	0.00826	CcSEcCtD
Ketoprofen—SLCO1A2—spinal cord—malignant glioma	0.000512	0.0181	CbGeAlD
Ketoprofen—Erythema multiforme—Temozolomide—malignant glioma	0.000505	0.00813	CcSEcCtD
Ketoprofen—Tinnitus—Temozolomide—malignant glioma	0.000498	0.00802	CcSEcCtD
Ketoprofen—Flushing—Temozolomide—malignant glioma	0.000496	0.00798	CcSEcCtD
Ketoprofen—Arrhythmia—Carmustine—malignant glioma	0.000494	0.00795	CcSEcCtD
Ketoprofen—Alopecia—Carmustine—malignant glioma	0.000489	0.00786	CcSEcCtD
Ketoprofen—PTGS2—embryo—malignant glioma	0.000486	0.0172	CbGeAlD
Ketoprofen—Erythema—Carmustine—malignant glioma	0.000482	0.00775	CcSEcCtD
Ketoprofen—Chills—Temozolomide—malignant glioma	0.00048	0.00772	CcSEcCtD
Ketoprofen—Alopecia—Temozolomide—malignant glioma	0.000472	0.0076	CcSEcCtD
Ketoprofen—Erythema—Temozolomide—malignant glioma	0.000465	0.00749	CcSEcCtD
Ketoprofen—Dysgeusia—Temozolomide—malignant glioma	0.000456	0.00733	CcSEcCtD
Ketoprofen—Carprofen—PTGS1—malignant glioma	0.000448	0.0604	CrCbGaD
Ketoprofen—Ketorolac—PTGS1—malignant glioma	0.000448	0.0604	CrCbGaD
Ketoprofen—Anaemia—Carmustine—malignant glioma	0.000445	0.00716	CcSEcCtD
Ketoprofen—Ill-defined disorder—Temozolomide—malignant glioma	0.000432	0.00695	CcSEcCtD
Ketoprofen—Anaemia—Temozolomide—malignant glioma	0.00043	0.00692	CcSEcCtD
Ketoprofen—Bromfenac—PTGS1—malignant glioma	0.000429	0.0579	CrCbGaD
Ketoprofen—Angioedema—Temozolomide—malignant glioma	0.000425	0.00684	CcSEcCtD
Ketoprofen—Malaise—Temozolomide—malignant glioma	0.00042	0.00675	CcSEcCtD
Ketoprofen—Vertigo—Temozolomide—malignant glioma	0.000418	0.00673	CcSEcCtD
Ketoprofen—Convulsion—Carmustine—malignant glioma	0.000417	0.00671	CcSEcCtD
Ketoprofen—Hypertension—Carmustine—malignant glioma	0.000416	0.00669	CcSEcCtD
Ketoprofen—SLCO1A2—central nervous system—malignant glioma	0.000415	0.0147	CbGeAlD
Ketoprofen—PTGS1—telencephalon—malignant glioma	0.000414	0.0147	CbGeAlD
Ketoprofen—Palpitations—Temozolomide—malignant glioma	0.000411	0.00661	CcSEcCtD
Ketoprofen—Myalgia—Carmustine—malignant glioma	0.00041	0.00659	CcSEcCtD
Ketoprofen—Anxiety—Carmustine—malignant glioma	0.000409	0.00657	CcSEcCtD
Ketoprofen—SLCO1A2—cerebellum—malignant glioma	0.000406	0.0144	CbGeAlD
Ketoprofen—Convulsion—Temozolomide—malignant glioma	0.000403	0.00649	CcSEcCtD
Ketoprofen—Hypertension—Temozolomide—malignant glioma	0.000402	0.00646	CcSEcCtD
Ketoprofen—ABCC4—central nervous system—malignant glioma	0.0004	0.0142	CbGeAlD
Ketoprofen—SLC22A8—central nervous system—malignant glioma	0.000396	0.014	CbGeAlD
Ketoprofen—Confusional state—Carmustine—malignant glioma	0.000396	0.00637	CcSEcCtD
Ketoprofen—Myalgia—Temozolomide—malignant glioma	0.000396	0.00637	CcSEcCtD
Ketoprofen—PTGS2—telencephalon—malignant glioma	0.000396	0.014	CbGeAlD
Ketoprofen—Anxiety—Temozolomide—malignant glioma	0.000395	0.00635	CcSEcCtD
Ketoprofen—Oedema—Carmustine—malignant glioma	0.000393	0.00632	CcSEcCtD
Ketoprofen—Discomfort—Temozolomide—malignant glioma	0.000391	0.0063	CcSEcCtD
Ketoprofen—Infection—Carmustine—malignant glioma	0.00039	0.00628	CcSEcCtD
Ketoprofen—Dry mouth—Temozolomide—malignant glioma	0.000387	0.00623	CcSEcCtD
Ketoprofen—Thrombocytopenia—Carmustine—malignant glioma	0.000385	0.00619	CcSEcCtD
Ketoprofen—Tachycardia—Carmustine—malignant glioma	0.000384	0.00617	CcSEcCtD
Ketoprofen—Confusional state—Temozolomide—malignant glioma	0.000383	0.00616	CcSEcCtD
Ketoprofen—Anaphylactic shock—Temozolomide—malignant glioma	0.00038	0.00611	CcSEcCtD
Ketoprofen—Oedema—Temozolomide—malignant glioma	0.00038	0.00611	CcSEcCtD
Ketoprofen—Infection—Temozolomide—malignant glioma	0.000377	0.00607	CcSEcCtD
Ketoprofen—Anorexia—Carmustine—malignant glioma	0.000375	0.00603	CcSEcCtD
Ketoprofen—Warfarin—CYP2C18—malignant glioma	0.000373	0.0504	CrCbGaD
Ketoprofen—Thrombocytopenia—Temozolomide—malignant glioma	0.000372	0.00598	CcSEcCtD
Ketoprofen—Hyperhidrosis—Temozolomide—malignant glioma	0.000367	0.00591	CcSEcCtD
Ketoprofen—Tiaprofenic acid—PTGS1—malignant glioma	0.000365	0.0493	CrCbGaD
Ketoprofen—Anorexia—Temozolomide—malignant glioma	0.000362	0.00582	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000358	0.00576	CcSEcCtD
Ketoprofen—Insomnia—Carmustine—malignant glioma	0.000355	0.00572	CcSEcCtD
Ketoprofen—Paraesthesia—Carmustine—malignant glioma	0.000353	0.00568	CcSEcCtD
Ketoprofen—Dyspnoea—Carmustine—malignant glioma	0.00035	0.00564	CcSEcCtD
Ketoprofen—Somnolence—Carmustine—malignant glioma	0.000349	0.00562	CcSEcCtD
Ketoprofen—Nepafenac—PTGS1—malignant glioma	0.000347	0.0468	CrCbGaD
Ketoprofen—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000346	0.00557	CcSEcCtD
Ketoprofen—Insomnia—Temozolomide—malignant glioma	0.000344	0.00553	CcSEcCtD
Ketoprofen—Decreased appetite—Carmustine—malignant glioma	0.000342	0.0055	CcSEcCtD
Ketoprofen—Paraesthesia—Temozolomide—malignant glioma	0.000341	0.00549	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Carmustine—malignant glioma	0.000339	0.00546	CcSEcCtD
Ketoprofen—Magnesium salicylate—PTGS1—malignant glioma	0.000339	0.0458	CrCbGaD
Ketoprofen—Dyspnoea—Temozolomide—malignant glioma	0.000339	0.00545	CcSEcCtD
Ketoprofen—Somnolence—Temozolomide—malignant glioma	0.000338	0.00543	CcSEcCtD
Ketoprofen—Constipation—Carmustine—malignant glioma	0.000336	0.00541	CcSEcCtD
Ketoprofen—Dyspepsia—Temozolomide—malignant glioma	0.000334	0.00538	CcSEcCtD
Ketoprofen—Fenbufen—PTGS1—malignant glioma	0.000332	0.0448	CrCbGaD
Ketoprofen—Decreased appetite—Temozolomide—malignant glioma	0.00033	0.00531	CcSEcCtD
Ketoprofen—SLCO1A2—brain—malignant glioma	0.00033	0.0117	CbGeAlD
Ketoprofen—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000328	0.00527	CcSEcCtD
Ketoprofen—ALB—brain—malignant glioma	0.000328	0.0116	CbGeAlD
Ketoprofen—Fatigue—Temozolomide—malignant glioma	0.000327	0.00527	CcSEcCtD
Ketoprofen—Constipation—Temozolomide—malignant glioma	0.000325	0.00522	CcSEcCtD
Ketoprofen—Feeling abnormal—Carmustine—malignant glioma	0.000324	0.00521	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Carmustine—malignant glioma	0.000321	0.00517	CcSEcCtD
Ketoprofen—ABCC4—brain—malignant glioma	0.000317	0.0112	CbGeAlD
Ketoprofen—SLC22A8—brain—malignant glioma	0.000315	0.0111	CbGeAlD
Ketoprofen—Feeling abnormal—Temozolomide—malignant glioma	0.000313	0.00503	CcSEcCtD
Ketoprofen—PTGS2—medulla oblongata—malignant glioma	0.000311	0.011	CbGeAlD
Ketoprofen—Abdominal pain—Carmustine—malignant glioma	0.000311	0.005	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Temozolomide—malignant glioma	0.000311	0.005	CcSEcCtD
Ketoprofen—Urticaria—Temozolomide—malignant glioma	0.000302	0.00485	CcSEcCtD
Ketoprofen—Abdominal pain—Temozolomide—malignant glioma	0.0003	0.00483	CcSEcCtD
Ketoprofen—PTGS1—spinal cord—malignant glioma	0.00029	0.0103	CbGeAlD
Ketoprofen—Hypersensitivity—Carmustine—malignant glioma	0.00029	0.00466	CcSEcCtD
Ketoprofen—Salsalate—PTGS1—malignant glioma	0.000288	0.0389	CrCbGaD
Ketoprofen—PTGS2—midbrain—malignant glioma	0.000284	0.0101	CbGeAlD
Ketoprofen—Asthenia—Carmustine—malignant glioma	0.000282	0.00454	CcSEcCtD
Ketoprofen—Hypersensitivity—Temozolomide—malignant glioma	0.00028	0.0045	CcSEcCtD
Ketoprofen—PTGS2—spinal cord—malignant glioma	0.000277	0.00982	CbGeAlD
Ketoprofen—Suprofen—PTGS1—malignant glioma	0.000276	0.0373	CrCbGaD
Ketoprofen—Asthenia—Temozolomide—malignant glioma	0.000272	0.00438	CcSEcCtD
Ketoprofen—Diarrhoea—Carmustine—malignant glioma	0.000269	0.00433	CcSEcCtD
Ketoprofen—Pruritus—Temozolomide—malignant glioma	0.000269	0.00432	CcSEcCtD
Ketoprofen—Dizziness—Carmustine—malignant glioma	0.00026	0.00418	CcSEcCtD
Ketoprofen—Diarrhoea—Temozolomide—malignant glioma	0.00026	0.00418	CcSEcCtD
Ketoprofen—Carprofen—PTGS2—malignant glioma	0.000256	0.0345	CrCbGaD
Ketoprofen—Ketorolac—PTGS2—malignant glioma	0.000256	0.0345	CrCbGaD
Ketoprofen—Dizziness—Temozolomide—malignant glioma	0.000251	0.00404	CcSEcCtD
Ketoprofen—Vomiting—Carmustine—malignant glioma	0.00025	0.00402	CcSEcCtD
Ketoprofen—Rash—Carmustine—malignant glioma	0.000248	0.00399	CcSEcCtD
Ketoprofen—Dermatitis—Carmustine—malignant glioma	0.000248	0.00398	CcSEcCtD
Ketoprofen—Headache—Carmustine—malignant glioma	0.000246	0.00396	CcSEcCtD
Ketoprofen—Bromfenac—PTGS2—malignant glioma	0.000245	0.0331	CrCbGaD
Ketoprofen—Vomiting—Temozolomide—malignant glioma	0.000241	0.00388	CcSEcCtD
Ketoprofen—Rash—Temozolomide—malignant glioma	0.000239	0.00385	CcSEcCtD
Ketoprofen—Dermatitis—Temozolomide—malignant glioma	0.000239	0.00385	CcSEcCtD
Ketoprofen—Fenoprofen—PTGS1—malignant glioma	0.000238	0.0322	CrCbGaD
Ketoprofen—Headache—Temozolomide—malignant glioma	0.000238	0.00383	CcSEcCtD
Ketoprofen—PTGS1—central nervous system—malignant glioma	0.000235	0.00833	CbGeAlD
Ketoprofen—Nausea—Carmustine—malignant glioma	0.000233	0.00375	CcSEcCtD
Ketoprofen—CYP2C8—brain—malignant glioma	0.00023	0.00816	CbGeAlD
Ketoprofen—Modafinil—CYP2B6—malignant glioma	0.000227	0.0306	CrCbGaD
Ketoprofen—Nausea—Temozolomide—malignant glioma	0.000226	0.00363	CcSEcCtD
Ketoprofen—PTGS2—central nervous system—malignant glioma	0.000225	0.00797	CbGeAlD
Ketoprofen—Mefenamic acid—PTGS1—malignant glioma	0.000221	0.0298	CrCbGaD
Ketoprofen—PTGS2—cerebellum—malignant glioma	0.00022	0.00779	CbGeAlD
Ketoprofen—Naproxen—PTGS1—malignant glioma	0.000217	0.0293	CrCbGaD
Ketoprofen—Tiaprofenic acid—PTGS2—malignant glioma	0.000209	0.0282	CrCbGaD
Ketoprofen—Nepafenac—PTGS2—malignant glioma	0.000198	0.0268	CrCbGaD
Ketoprofen—Magnesium salicylate—PTGS2—malignant glioma	0.000194	0.0262	CrCbGaD
Ketoprofen—Modafinil—SLC6A3—malignant glioma	0.000193	0.0261	CrCbGaD
Ketoprofen—Fenbufen—PTGS2—malignant glioma	0.00019	0.0256	CrCbGaD
Ketoprofen—PTGS1—brain—malignant glioma	0.000187	0.00662	CbGeAlD
Ketoprofen—PTGS2—brain—malignant glioma	0.000179	0.00632	CbGeAlD
Ketoprofen—Atomoxetine—SLC6A3—malignant glioma	0.000166	0.0225	CrCbGaD
Ketoprofen—Salsalate—PTGS2—malignant glioma	0.000165	0.0223	CrCbGaD
Ketoprofen—Suprofen—PTGS2—malignant glioma	0.000158	0.0213	CrCbGaD
Ketoprofen—Flurbiprofen—PTGS1—malignant glioma	0.000155	0.021	CrCbGaD
Ketoprofen—Fenoprofen—PTGS2—malignant glioma	0.000136	0.0184	CrCbGaD
Ketoprofen—Mefenamic acid—PTGS2—malignant glioma	0.000126	0.0171	CrCbGaD
Ketoprofen—Naproxen—PTGS2—malignant glioma	0.000124	0.0167	CrCbGaD
Ketoprofen—Flurbiprofen—PTGS2—malignant glioma	8.89e-05	0.012	CrCbGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.67e-05	0.000133	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP2B6—malignant glioma	1.66e-05	0.000133	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.66e-05	0.000133	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP2B6—malignant glioma	1.65e-05	0.000132	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.65e-05	0.000132	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—GSTP1—malignant glioma	1.65e-05	0.000132	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SPP1—malignant glioma	1.62e-05	0.00013	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CAT—malignant glioma	1.6e-05	0.000128	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—H3F3A—malignant glioma	1.59e-05	0.000127	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MYC—malignant glioma	1.58e-05	0.000126	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—BCHE—malignant glioma	1.57e-05	0.000126	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	1.57e-05	0.000126	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PDGFB—malignant glioma	1.57e-05	0.000125	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—SLC5A5—malignant glioma	1.55e-05	0.000124	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EGFR—malignant glioma	1.54e-05	0.000123	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL2—malignant glioma	1.54e-05	0.000123	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TERT—malignant glioma	1.54e-05	0.000123	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.52e-05	0.000122	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—IDH1—malignant glioma	1.52e-05	0.000122	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—KRAS—malignant glioma	1.52e-05	0.000122	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—IDH1—malignant glioma	1.51e-05	0.000121	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—NCOR1—malignant glioma	1.51e-05	0.000121	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PDGFB—malignant glioma	1.5e-05	0.00012	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—JAG1—malignant glioma	1.5e-05	0.00012	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FGFR1—malignant glioma	1.49e-05	0.000119	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—CAV1—malignant glioma	1.49e-05	0.000119	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SPHK1—malignant glioma	1.47e-05	0.000118	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.47e-05	0.000118	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.47e-05	0.000118	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HIF1A—malignant glioma	1.47e-05	0.000118	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FBXW7—malignant glioma	1.47e-05	0.000117	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SPHK1—malignant glioma	1.46e-05	0.000117	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KRAS—malignant glioma	1.46e-05	0.000117	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.46e-05	0.000117	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CYP2C18—malignant glioma	1.44e-05	0.000115	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—IDH2—malignant glioma	1.44e-05	0.000115	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CYP2C18—malignant glioma	1.43e-05	0.000115	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTT1—malignant glioma	1.43e-05	0.000115	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CAV1—malignant glioma	1.42e-05	0.000114	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—F2—malignant glioma	1.41e-05	0.000113	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—FN1—malignant glioma	1.41e-05	0.000113	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KDR—malignant glioma	1.4e-05	0.000112	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—PIK3CA—malignant glioma	1.4e-05	0.000112	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.39e-05	0.000111	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.36e-05	0.000109	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.36e-05	0.000109	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.35e-05	0.000108	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CG—malignant glioma	1.35e-05	0.000108	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—F2—malignant glioma	1.35e-05	0.000108	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FN1—malignant glioma	1.35e-05	0.000108	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.35e-05	0.000108	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—malignant glioma	1.35e-05	0.000108	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTGS1—malignant glioma	1.34e-05	0.000107	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PIK3CA—malignant glioma	1.34e-05	0.000107	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.34e-05	0.000107	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—EGF—malignant glioma	1.34e-05	0.000107	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—BAD—malignant glioma	1.34e-05	0.000107	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PTPN11—malignant glioma	1.33e-05	0.000106	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NOTCH1—malignant glioma	1.32e-05	0.000106	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CD80—malignant glioma	1.3e-05	0.000104	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—malignant glioma	1.3e-05	0.000104	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—APC—malignant glioma	1.29e-05	0.000104	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CG—malignant glioma	1.29e-05	0.000104	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGF—malignant glioma	1.28e-05	0.000102	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTPN11—malignant glioma	1.27e-05	0.000102	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.27e-05	0.000102	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—GSTP1—malignant glioma	1.25e-05	0.0001	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—BCHE—malignant glioma	1.25e-05	9.99e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.24e-05	9.91e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—IDH1—malignant glioma	1.24e-05	9.91e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT2—malignant glioma	1.24e-05	9.9e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—SLC5A5—malignant glioma	1.23e-05	9.87e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—CAV1—malignant glioma	1.23e-05	9.86e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.23e-05	9.86e-05	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.23e-05	9.81e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CAT—malignant glioma	1.22e-05	9.75e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—BRAF—malignant glioma	1.22e-05	9.73e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SPHK1—malignant glioma	1.2e-05	9.59e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.2e-05	9.57e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CD—malignant glioma	1.19e-05	9.52e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.19e-05	9.51e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT2—malignant glioma	1.18e-05	9.47e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EGFR—malignant glioma	1.18e-05	9.43e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.18e-05	9.42e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.17e-05	9.39e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.17e-05	9.33e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTT1—malignant glioma	1.17e-05	9.33e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTT1—malignant glioma	1.16e-05	9.28e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—NCOR1—malignant glioma	1.15e-05	9.2e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CDKN2B—malignant glioma	1.15e-05	9.2e-05	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—AKT1—malignant glioma	1.14e-05	9.13e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CD—malignant glioma	1.14e-05	9.1e-05	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—PIK3CA—malignant glioma	1.13e-05	9.02e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CG—malignant glioma	1.12e-05	8.98e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KRAS—malignant glioma	1.11e-05	8.91e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.11e-05	8.86e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HES1—malignant glioma	1.1e-05	8.77e-05	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—AKT1—malignant glioma	1.09e-05	8.76e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS1—malignant glioma	1.09e-05	8.75e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NCOR1—malignant glioma	1.09e-05	8.72e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FGF2—malignant glioma	1.09e-05	8.72e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.09e-05	8.71e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS1—malignant glioma	1.09e-05	8.7e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PPARG—malignant glioma	1.08e-05	8.67e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.08e-05	8.66e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—RAF1—malignant glioma	1.06e-05	8.5e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PDGFRA—malignant glioma	1.04e-05	8.35e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CB—malignant glioma	1.04e-05	8.29e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—PIK3CA—malignant glioma	1.02e-05	8.19e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MDM2—malignant glioma	1.02e-05	8.16e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—BCHE—malignant glioma	1.02e-05	8.13e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—RAF1—malignant glioma	1.02e-05	8.13e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—BCHE—malignant glioma	1.01e-05	8.08e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.01e-05	8.07e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.01e-05	8.07e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ERBB2—malignant glioma	1e-05	8.04e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—SLC5A5—malignant glioma	1e-05	8.03e-05	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1e-05	8.01e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—SLC5A5—malignant glioma	9.98e-06	7.99e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—GSTP1—malignant glioma	9.94e-06	7.95e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CB—malignant glioma	9.92e-06	7.93e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CD—malignant glioma	9.87e-06	7.9e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	9.73e-06	7.79e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CAT—malignant glioma	9.67e-06	7.74e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TERT—malignant glioma	9.61e-06	7.69e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HLA-A—malignant glioma	9.61e-06	7.69e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IL2—malignant glioma	9.52e-06	7.62e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTT1—malignant glioma	9.49e-06	7.6e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.49e-06	7.59e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.44e-06	7.55e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.4e-06	7.53e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PDGFB—malignant glioma	9.38e-06	7.5e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—CAV1—malignant glioma	9.38e-06	7.5e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.35e-06	7.48e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FGFR1—malignant glioma	9.33e-06	7.47e-05	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—AKT1—malignant glioma	9.21e-06	7.37e-05	CbGpPWpGaD
Ketoprofen—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	9.19e-06	7.35e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HIF1A—malignant glioma	9.19e-06	7.35e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—NCOR1—malignant glioma	9.13e-06	7.31e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CASP3—malignant glioma	9.12e-06	7.3e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL2—malignant glioma	9.11e-06	7.29e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.96e-06	7.17e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS1—malignant glioma	8.9e-06	7.12e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CAV1—malignant glioma	8.89e-06	7.11e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	8.86e-06	7.09e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MMP9—malignant glioma	8.62e-06	6.9e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CB—malignant glioma	8.6e-06	6.88e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PTEN—malignant glioma	8.57e-06	6.86e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CG—malignant glioma	8.54e-06	6.83e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTGS2—malignant glioma	8.52e-06	6.82e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—AKT1—malignant glioma	8.36e-06	6.69e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—BAD—malignant glioma	8.36e-06	6.69e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NOTCH1—malignant glioma	8.28e-06	6.62e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—BCHE—malignant glioma	8.27e-06	6.62e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PPARG—malignant glioma	8.24e-06	6.6e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.2e-06	6.56e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—SLC5A5—malignant glioma	8.17e-06	6.54e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.16e-06	6.53e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CD80—malignant glioma	8.11e-06	6.49e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—APC—malignant glioma	8.1e-06	6.48e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—malignant glioma	8.09e-06	6.47e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—GSTP1—malignant glioma	8.08e-06	6.47e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—GSTP1—malignant glioma	8.04e-06	6.43e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGF—malignant glioma	8e-06	6.4e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PTPN11—malignant glioma	7.95e-06	6.36e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CAT—malignant glioma	7.87e-06	6.29e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CAT—malignant glioma	7.82e-06	6.26e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—malignant glioma	7.74e-06	6.19e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.73e-06	6.18e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—STAT3—malignant glioma	7.66e-06	6.13e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.65e-06	6.12e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—BRAF—malignant glioma	7.61e-06	6.09e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CD—malignant glioma	7.51e-06	6.01e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—CAV1—malignant glioma	7.44e-06	5.96e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PTEN—malignant glioma	7.43e-06	5.95e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—NCOR1—malignant glioma	7.43e-06	5.94e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT2—malignant glioma	7.41e-06	5.93e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—NCOR1—malignant glioma	7.39e-06	5.91e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MYC—malignant glioma	7.12e-06	5.7e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CD—malignant glioma	7.12e-06	5.69e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.11e-06	5.69e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGFR—malignant glioma	6.97e-06	5.57e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KRAS—malignant glioma	6.88e-06	5.5e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FGF2—malignant glioma	6.81e-06	5.45e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CG—malignant glioma	6.78e-06	5.42e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.68e-06	5.34e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KRAS—malignant glioma	6.58e-06	5.26e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—GSTP1—malignant glioma	6.58e-06	5.26e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CB—malignant glioma	6.54e-06	5.24e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PPARG—malignant glioma	6.54e-06	5.24e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTGS2—malignant glioma	6.48e-06	5.19e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CAT—malignant glioma	6.4e-06	5.12e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MDM2—malignant glioma	6.38e-06	5.1e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—RAF1—malignant glioma	6.35e-06	5.08e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PIK3CA—malignant glioma	6.32e-06	5.06e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ERBB2—malignant glioma	6.29e-06	5.03e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CB—malignant glioma	6.2e-06	4.96e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—malignant glioma	6.11e-06	4.89e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—CAV1—malignant glioma	6.06e-06	4.85e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—NCOR1—malignant glioma	6.05e-06	4.84e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PIK3CA—malignant glioma	6.05e-06	4.84e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—CAV1—malignant glioma	6.02e-06	4.82e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CD—malignant glioma	5.96e-06	4.77e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—malignant glioma	5.85e-06	4.68e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.79e-06	4.63e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.75e-06	4.6e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PTEN—malignant glioma	5.65e-06	4.52e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CG—malignant glioma	5.52e-06	4.41e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CG—malignant glioma	5.49e-06	4.39e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PTEN—malignant glioma	5.36e-06	4.29e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PPARG—malignant glioma	5.32e-06	4.26e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PPARG—malignant glioma	5.29e-06	4.24e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PIK3CA—malignant glioma	5.24e-06	4.2e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CB—malignant glioma	5.2e-06	4.16e-05	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—AKT1—malignant glioma	5.16e-06	4.13e-05	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—AKT1—malignant glioma	4.94e-06	3.95e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—CAV1—malignant glioma	4.93e-06	3.94e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CD—malignant glioma	4.85e-06	3.88e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CD—malignant glioma	4.82e-06	3.86e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—STAT3—malignant glioma	4.79e-06	3.84e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.71e-06	3.77e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.49e-06	3.59e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PTEN—malignant glioma	4.49e-06	3.59e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MYC—malignant glioma	4.45e-06	3.56e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGFR—malignant glioma	4.36e-06	3.49e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PPARG—malignant glioma	4.33e-06	3.47e-05	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—AKT1—malignant glioma	4.28e-06	3.43e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CB—malignant glioma	4.23e-06	3.38e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CB—malignant glioma	4.2e-06	3.36e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTGS2—malignant glioma	4.19e-06	3.35e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTGS2—malignant glioma	4.16e-06	3.33e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KRAS—malignant glioma	4.12e-06	3.29e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PIK3CA—malignant glioma	3.99e-06	3.19e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.95e-06	3.16e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PIK3CA—malignant glioma	3.78e-06	3.03e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PTEN—malignant glioma	3.65e-06	2.92e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PTEN—malignant glioma	3.63e-06	2.91e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.44e-06	2.75e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTGS2—malignant glioma	3.41e-06	2.73e-05	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—AKT1—malignant glioma	3.26e-06	2.61e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PIK3CA—malignant glioma	3.17e-06	2.53e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—AKT1—malignant glioma	3.09e-06	2.47e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PTEN—malignant glioma	2.97e-06	2.38e-05	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—AKT1—malignant glioma	2.59e-06	2.07e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.58e-06	2.06e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PIK3CA—malignant glioma	2.56e-06	2.05e-05	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—AKT1—malignant glioma	2.11e-06	1.68e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.1e-06	1.68e-05	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—AKT1—malignant glioma	2.09e-06	1.67e-05	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—AKT1—malignant glioma	1.71e-06	1.37e-05	CbGpPWpGaD
